Postmenopausal hormone replacement therapy and the vascular wall: Epidemiology and clinical studies;Postmenopausale hormonsubstitutionstherapie und die gefasswand: Epidemiologie und klinische studien

Vasa - Journal of Vascular Diseases

Volumn 29, Issue 4, 2000, Pages 243-251

  Joswig, M ^a   Hach Wunderle, V ^a   Holst, T V ^a   Nawroth, P P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Epidemiology; Estrogen; Postmenopausal hormone replacement therapy; Vascular wall

Indexed keywords

CONJUGATED ESTROGEN; DESOGESTREL; ESTRADIOL; ESTROGEN; GESTAGEN; NORGESTREL; PLACEBO;

ADULT; AGED; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HUMAN; MORTALITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0033669092     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.29.4.243     Document Type: Review

References (59)

1. Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women
2. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
3. Guidelines for estrogen and gestagen replacement in the climacteric and postmenopause. The 21st work meeting of the Zurich Discussion Group. November, 1998
4. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM
5. Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease
6. Clinical Synthesis Panel on HRT. Hormone replacement therapy
7. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease
8. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women
9. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study
10. Risk of venous thromboembolism in users of hormone replacement therapy
11. Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness
12. Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes
13. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement
14. Patient noncompliance with hormone replacement therapy: A nationwide estimate using a large prescription claims database
15. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort
16. The relationship of treatment adherence to the risk of death after myocardial infarction in women
17. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women
18. Invited commentary: Can selection bias explain the cardiovascular benefits of estrogen replacement therapy?
19. Postmenopausal hormone therapy and mortality
20. Prospective study of exogenous hormones and risk of pulmonary embolism in women
21. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease
22. Postmenopausal use of estrogen and occlusion of coronary arteries. Postmenopausal estrogen use and coronary atherosclerosis
23. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
24. Decreased mortality in users of estrogen replacement therapy
25. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease
26. Hormone replacement therapy with estradiol and risk of venous thromboembolism - A population-based case-control study
27. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
28. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index
29. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
30. Postmenopausal estrogens and risk of myocardial infarction in diabetic women
31. The protective effects of estrogen on the cardiovascular system
32. Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women
33. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm
34. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness
35. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions
36. Estrogen replacement therapy after coronary angioplasty in women
37. Postmenopausal oestrogen treatment and stroke: A prospective study
38. Hormone replacement therapy and risk of venous thromboembolism: Population based case-control study
39. Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy
40. Sonographic evaluation of carotid artery atherosclerosis in the elderly: Relationship of disease severity to stroke and transient ischemic attack
41. Cardioprotective effect of hormone replacement therapy in postmenopausal women: Is the evidence biased?
42. Combined oestrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women
43. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
44. Short-term anti-ischemic effect of 17beta-estradiol in postmenopausal women with coronary artery disease
45. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease
46. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe
47. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function
48. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)
49. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
50. The relationship between breast cancer survival and prior postmenopausal estrogen use
51. Evidence of a healthy estrogen user survivor effect
52. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting
53. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy
54. Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
55. Hormone replacement therapy and intima-media thickness of the common carotid artery: The Rotterdam study
56. Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys
57. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States
58. Design of the Women's Health Initiative clinical trial and observational study
59. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial